Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription Articles published in Arch Virol Retrieve available abstracts of 17 articles: HTML format

Single Articles

May 2025
1. SLEEM R, Salah A, Alziz AA, Daif AA, et al
   Inhibition of hepatitis C virus replication in HepG2 cells via modulation of the Raf-1 and interferon-alpha signaling pathways by thymoquinone.
   Arch Virol. 2025;170:120.
   PubMed     Abstract available
   
   
   
2. DA SILVA H, Juniastuti, Amin M, Soares J, et al
   Genotypes, subtypes, and genetic variability of hepatitis B virus from blood donors in Timor-Leste.
   Arch Virol. 2025;170:119.
   PubMed     Abstract available
   
   
   March 2025
3. SUPEKAR R, Sarkar J, Chakrabarti P, Biswas S, et al
   Diagnostic challenges due to hepatitis B virus surface antigen mutations outside the major hydrophilic region.
   Arch Virol. 2025;170:71.
   PubMed     Abstract available
   
   
   December 2024
4. BIRLEM GE, Sita A, Gularte JS, de Souza da Silva D, et al
   Detection of a novel hepacivirus in wild cavies (Cavia aperea aperea).
   Arch Virol. 2024;170:19.
   PubMed     Abstract available
   
   
   November 2024
5. TRIPATHY AS, Wagh P, Shahapure G, Walimbe AM, et al
   Association of IL1RN VNTR and NKG2A polymorphisms with hepatitis E infection, a case study from western India.
   Arch Virol. 2024;169:250.
   PubMed     Abstract available
   
   
   
6. JIAO Q, Zhu S, Liao B, Liu H, et al
   An NLR family member X1 mutation (p.Arg707Cys) suppresses hepatitis B virus infection in hepatocytes and favors the interaction of retinoic acid-inducible gene 1 with mitochondrial antiviral signaling protein.
   Arch Virol. 2024;169:238.
   PubMed     Abstract available
   
   
   
7. ALMAS I, Tariq S, Amin I, Shahid M, et al
   Molecular epidemiology and genetic characterization of hepatitis B virus in two major provinces of Pakistan.
   Arch Virol. 2024;169:239.
   PubMed     Abstract available
   
   
   October 2024
8. KHAN S, Aggarwal S, Bhatia P, Yadav AK, et al
   Glucose and glutamine drive hepatitis E virus replication.
   Arch Virol. 2024;169:233.
   PubMed     Abstract available
   
   
   September 2024
9. NJIFON AM, Modiyinji AF, Monamele CG, Mbouyap PR, et al
   A decade-long retrospective study of hepatitis C virus genetic diversity in Cameroon, 2013-2023: presence of a high proportion of unsubtypable and putative recombinant HCV strains.
   Arch Virol. 2024;169:197.
   PubMed     Abstract available
   
   
   June 2024
10. SHALABY S, Awadin W, Karam R, Salem S, et al
    Pathological and phylogenetic characterization of a rare fowl adenovirus (FAdV-8b) associated with inclusion body hepatitis in naturally infected Meleagris gallopavo.
    Arch Virol. 2024;169:146.
    PubMed     Abstract available
    
    
    April 2024
11. DAS S, Behera P, Shewale DJ, Bodele J, et al
    Development of an effective single-chain variable fragment recognizing a novel epitope in the hepatitis C virus E2 protein that restricts virus entry into hepatocytes.
    Arch Virol. 2024;169:112.
    PubMed     Abstract available
    
    
    
12. SEDOHARA A, Takahashi K, Arai K, Arizono K, et al
    Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022.
    Arch Virol. 2024;169:103.
    PubMed     Abstract available
    
    
    
13. WANG S, Xie Y, Liu F, Wang J, et al
    miR-3188 inhibits hepatitis B virus transcription by targeting Bcl-2.
    Arch Virol. 2024;169:88.
    PubMed     Abstract available
    
    
    February 2024
14. SAID EM, Abdulaziz BA, Kassas ME, El Attar IH, et al
    Retraction Note: High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir the
    Arch Virol. 2024;169:45.
    PubMed    
    
    
    January 2024
15. MA X, Li Y, Zhu H, Lu K, et al
    ENPP1 inhibits the transcription activity of the hepatitis B virus pregenomic promoter by upregulating the acetylation of LMNB1.
    Arch Virol. 2024;169:36.
    PubMed     Abstract available
    
    
    
16. GUPTA S, Parveen S
    Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach.
    Arch Virol. 2024;169:33.
    PubMed     Abstract available
    
    
    October 2023
17. GAO H, Fan H, Xie H
    miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of the enhancer I/X promoter.
    Arch Virol. 2023;168:282.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.